HEALTHCARE

20 Jun 2019

Emirates Hospital - Jumeirah receives ‘Superbrands’ recognition

Jumeirah was recognized as one of UAE’s strongest brands at the 15th annual Superbrands tribute event, held on June 18 at the Intercontinental Dubai-Festival City. Out of approximately 150 leading brands, 48 brands from the UAE were awarded Superbrand Status at the event, considered"...

Continue Reading

19 Jun 2019

GSK to launch new production line for VoltarenEmulgel in Egypt

Cairo: GSK Consumer Healthcare is inaugurating VoltarenEmulgel semi-solid production line in the SmithKline Beecham manufacturing facility in Giza.

This semi-solid production line is developed to be a state of"...

Continue Reading

19 Jun 2019

India’s largest fitness chain cult.fit enters UAE

Integrated healthcare platform cure.fit launched its new fitness revolution centre, cult.fit in Dubai at Palm Strip Mall. Headquartered in Bengaluru India, the holistic healthcare company was founded in 2016 by Mukesh Bansal and Ankit Nagori with the"...

Continue Reading

19 Jun 2019

Ferring Collaboration with Digital Health Innovators WOOM Aims to Help More People Build Families Faster

Ferring Pharmaceuticals and WOOM today announced a collaboration, which aims to improve and shorten the fertility journeys of the one in six couples who have difficulty conceiving.1

The WOOM ovulation and fertility"...

Continue Reading

18 Jun 2019

Egypt to reduce medical training, increase doctor numbers

The Egyptian government has launched a drive to encourage more people to study medicine and enter into the profession after scores have changed field or left to work abroad as the government tackles increasing debt and a budget deficit.

President"...

Continue Reading

18 Jun 2019

Fakih IVF Supports “Year of Tolerance”

Aligning with the principles set forth for the “Year of Tolerance,” Fakih IVF Fertility Center is reaching out to individuals in an effort to promote the values of tolerance.

The campaign titled “Positive"...

Continue Reading

18 Jun 2019

Boehringer Ingelheim and OSE Immunotherapeutics Announce Dosing Of the First Patient in a Phase 1 Trial of SIRPα Antagonist Monoclonal Antibody, BI 765063, in Patients with Advanced Solid Tumors

Boehringer Ingelheim and OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnémo: OSE) today announce that the first patient has been dosed in the first-in-human Phase 1 clinical trial evaluating BI 765063, formerly OSE-172, a first-in-class monoclonal antibody antagonist of SIRPα,"...

Continue Reading

17 Jun 2019

Cleopatra Hospital to acquire majority Stake in One of largest IVF fertility centres

ArabFinance: Cleopatra Hospital Group S.A.E. (CLHO), Egypt’s largest private hospital group by number of hospital beds and number of operating hospitals, has announced it has entered into an exclusive agreement to acquire a majority stake in one of Egypt’s largest In Vitro Fertilization"...

Continue Reading

11 Jun 2019

New Analysis Shows Sleep Apnea More Common in Americas than Previously Thought

ResMed (NYSE: RMD) (ASX: RMD) revealed roughly 170 million people across North and South America have sleep apnea, according to a study it presented at the annual SLEEP meeting hosted by the American Academy of Sleep Medicine (AASM) and the Sleep Research Society.

The"...

Continue Reading

11 Jun 2019

Boehringer Ingelheim and University of Dundee Highlight Successful PROTAC Drug Discovery Program and Extend Their Ongoing Anti-Cancer Alliance

  • Boehringer Ingelheim and University of Dundee achieve milestone in collaboration aimed at developing novel protein degradation medicines
  • Results published in Nature Chemical Biology showcase the use of the broadly applicable structure-based PROTAC design approach to discover highly potent and selective drug candidates
  • The first PROTAC...

    Continue Reading
Found articles: - Pages  
Contact US | Powered by CNPHUB.com - All Rights Reserved